Victory Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Buy |
|
|||||
|
2025
Q1 | $2.91M | Buy |
|
|||||
|
2024
Q4 | $1.52M | Buy |
|
|||||
|
2024
Q3 | $1.4M | Buy |
|
|||||
|
2024
Q2 | $659K | Sell |
|
|||||
|
2024
Q1 | $660K | Sell |
|
|||||
|
2023
Q4 | $1.53M | Buy |
|
|||||
|
2023
Q3 | $1.04M | Buy |
|
|||||
|
2023
Q2 | $703K | Buy |
|
|||||
|
2023
Q1 | $210K | Sell |
|
|||||
|
2022
Q4 | $241K | Sell |
|
|||||
|
2022
Q3 | $2.35M | Sell |
|
|||||
|
2022
Q2 | $2.73M | Sell |
|
|||||
|
2022
Q1 | $3.43M | Buy |
|
|||||
|
2021
Q4 | $4.11M | Sell |
|
|||||
|
2021
Q3 | $4.64M | Sell |
|
|||||
|
2021
Q2 | $4.57M | Sell |
|
|||||
|
2021
Q1 | $5.89M | Buy |
|
|||||
|
2020
Q4 | $588K | Sell |
|
|||||
|
2020
Q3 | $24.6M | Sell |
|
|||||
|
2020
Q2 | $30.5M | Sell |
|
|||||
|
2020
Q1 | $42.8M | Buy |
|
|||||
|
2019
Q4 | $31.5M | Sell |
|
|||||
|
2019
Q3 | $40.6M | Sell |
|
|||||
|
2019
Q2 | $67M | Sell |
|
|||||
|
2019
Q1 | $82.4M | Buy |
|
|||||
|
2018
Q4 | $63.7M | Buy |
|
|||||
|
2018
Q3 | $120M | Sell |
|
|||||
|
2018
Q2 | $111M | Buy |
|
|||||
|
2018
Q1 | $84.3M | Sell |
|
|||||
|
2017
Q4 | $72.3M | Sell |
|
|||||
|
2017
Q3 | $90M | Sell |
|
|||||
|
2017
Q2 | $82.4M | Sell |
|
|||||
|
2017
Q1 | $72.2M | Sell |
|
|||||
|
2016
Q4 | $98.1M | Buy |
|
|||||
|
2016
Q3 | $95.9M | Buy |
|
|||||
|
2016
Q2 | $66K | Buy |
|
|||||
|
2016
Q1 | $34K | Sell |
|
|||||
|
2015
Q4 | $61K | Sell |
|
|||||
|
2015
Q3 | $50K | Sell |
|
|||||
|
2015
Q2 | $65K | Buy |
|